Minnesota is the seventh state to approve a new 340B contract pharmacy law that forbids drug manufacturers and distributors from limiting access to medications for hospitals and health systems serving uninsured and underinsured populations.

Bristol Myers Squibb, one of 12 pharmaceutical and health service companies in the Fortune 500 list, plans to lay off 863 employees in Lawrenceville, N.J., according to recently filed WARN notices. 

Beginning June 18, a newly finalized rule from the Health Resources and Services Administration will take effect and change how the resolution of disputes within the 340B program is handled.

CEOs of two U.S. health systems testified June 4 before a House subcommittee on the oversight of the 340B drug pricing program, advocating for the preservation of the protections that have been in place for hospitals and patients since 1992.

After a medication error or an unexpected patient outcome, it is common for practitioners to question themselves and feel shame and guilt, according to the American Society of Health-System Pharmacists. 

All retail, home delivery and specialty pharmacies operated by Ascension resumed normal operations as of June 4, according to the St. Louis-based organization recovering from a cyberattack. 

Additional updates are needed to reduce the risk of medication errors associated with automated dispensing cabinets, the Institute for Safe Medication Practices said May 31. 

Louisville, Ky.-based Baptist Health is slated to open one of the nation's first autonomous pharmacy centers June 5. 

The FDA has given the green light to Moderna's mRNA-based respiratory syncytial virus vaccine, specifically for older adults, the drugmaker announced May 31.

The growth and complexity of biosimilar agents for infusion therapy is generating a need for effective tools to optimize product selection and manage costs. Frequent changes in payer policies lead to frustrating delays in the authorization process and create obstacles…